Iradimed (IRMD) EV to CFO (2014 - 2026)

Iradimed (IRMD) has reported EV to CFO for 13 consecutive years, with 195.76 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to CFO rose 114.34% year-over-year to 195.76 in Q2 2026; TTM through Jun 2026 was 42.85, a 64.37% increase from a year earlier, with the FY2025 full-year figure at 47.79, up 89.33% from the prior year.
• EV to CFO was 195.76 for Q2 2026 at Iradimed, up from 141.63 in the prior quarter.
• Over five years, EV to CFO peaked at 367.95 in Q3 2023 and troughed at 64.22 in Q3 2024.
• A 5-year average of 155.99 and a median of 136.37 in 2023 frame the typical range for EV to CFO.
• Across the five-year window, EV to CFO jumped 350.06% in 2023 and tumbled 82.55% in 2024, its largest moves.
• Over 5 years, EV to CFO stood at 98.14 in 2022, then jumped by 43.56% to 140.89 in 2023, then declined by 23.31% to 108.04 in 2024, then jumped by 86.32% to 201.31 in 2025, then dropped by 2.75% to 195.76 in 2026.
• The last three EV to CFO figures came in at 195.76 (Q2 2026), 141.63 (Q1 2026), and 201.31 (Q4 2025), per Business Quant data.